The U.S. Department of Veterans Affairs (VA) will be conducting a 160-person study to assess the impact on quality of life (QOL) resulting from use of the ReWalk Robotics Personal 6.0 Exoskeleton Systems. Veterans with spinal cord injuries will be recruited nationwide. The study will begin in October, with an estimated completion date of June 2020. Six VA Medical Centers with Spinal Cord Injury Services will be participating: Long Beach and Palo Alto, California; Tampa, Florida; Jamaica Plain, Massachusetts; Houston; and Richmond, Virginia.
The VA released full details of the study, including eligibility and exclusion and inclusion criteria, on the clinical trials section of the National Institutes of Health (NIH) website. The study is titled, Exoskeleton Assisted-Walking in Persons With SCI: Impact on Quality of Life (www.clinicaltrials.gov Identifier: NCT02658656).
